|
Volumn , Issue , 1999, Pages 249-261
|
Cardiac transplantation in over 1000 patients: a single institution experience from Columbia University.
a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
DACLIZUMAB;
IMMUNOGLOBULIN G;
IMMUNOSUPPRESSIVE AGENT;
MONOCLONAL ANTIBODY;
ADULT;
ARTICLE;
CLASSIFICATION;
CONGENITAL HEART MALFORMATION;
DISEASE FREE SURVIVAL;
DONOR;
DRUG COMBINATION;
FEMALE;
GRAFT REJECTION;
HEART ASSIST DEVICE;
HEART DISEASE;
HEART TRANSPLANTATION;
HUMAN;
MALE;
MORTALITY;
PATIENT SELECTION;
PHYSIOLOGY;
POSTOPERATIVE COMPLICATION;
REOPERATION;
RETROSPECTIVE STUDY;
STATISTICAL ANALYSIS;
STATISTICS;
SURVIVAL RATE;
SURVIVOR;
TIME;
UNITED STATES;
UNIVERSITY HOSPITAL;
ACTUARIAL ANALYSIS;
ADULT;
ANTIBODIES, MONOCLONAL;
DISEASE-FREE SURVIVAL;
DRUG THERAPY, COMBINATION;
FEMALE;
GRAFT REJECTION;
HEART DEFECTS, CONGENITAL;
HEART DISEASES;
HEART TRANSPLANTATION;
HEART-ASSIST DEVICES;
HOSPITALS, UNIVERSITY;
HUMANS;
IMMUNOGLOBULIN G;
IMMUNOSUPPRESSIVE AGENTS;
MALE;
NEW YORK CITY;
PATIENT SELECTION;
POSTOPERATIVE COMPLICATIONS;
REOPERATION;
RETROSPECTIVE STUDIES;
SURVIVAL RATE;
SURVIVORS;
TIME FACTORS;
TISSUE DONORS;
|
EID: 0033286619
PISSN: 08909016
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (22)
|
References (0)
|